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Oxidative stressIn this study, the effects of caffeine (CAF) and SCH58261, a selective A2A receptor antagonist, on memory
impairment and oxidative stress generated by aging in rats were investigated. Young and aged rats were treated
daily per 10 days with CAF (30 mg/kg p.o.) or SCH58261 (0.5 mg/kg, p.o.) or vehicle (1 ml/kg p.o.). Rats were
trained and tested in a novel object recognition task. After the behavioral test, ascorbic acid and oxygen and
nitrogen reactive species levels as well as Na+K+ ATPase activity were determined in rat brain. The results
demonstrated that the age-relatedmemory deﬁcit was reversed by treatment with CAF or SCH58261. Treatment
with CAF or SCH58261 signiﬁcantly normalized oxygen and nitrogen reactive species levels increased in brains of
aged rats. Na+K+ ATPase activity inhibited in brains of aged rats was also normalized by CAF or SCH58261
treatment. A decrease in basal ascorbic acid levels in brains of aged rats was not changed by CAF or SCH58261.
These results demonstrated that CAF and SCH58261,modulators of adenosinergic receptors, were able to reverse
age-associated memory impairment and to partially reduce oxidative stress.: +55 55 3220 8978.
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The cognitive function decline is closely relatedwith brain changes
generated by advancing age. Results of a previous study demonstrated
that cognitive impairment may be due to the excessive formation of
reactive species (RS) (Lu et al., 2006). The central nervous system
(CNS) is particularly more vulnerable to oxidative damage because of
its high oxygen consumption, high tissue concentration of iron (Dröge
and Schipper, 2007), high lipid contents and the low activity of its
antioxidant defenses (Halliwell, 1996). Moreover, Jayakumar et al.
(2007) have reported a decrease in enzymatic and non-enzymatic
antioxidant defenses in rat brain during aging.
Several drugs, caffeine (CAF) for example, have been exploited to
combatRSand theage-related changes. CAFand itsmetaboliteshavebeen
shown to present antioxidant effects (Gómez-Ruiz et al., 2007). Central
effects of CAFaremediatedbybinding inanon-selectiveway toadenosine
receptors in the brain. Four adenosine receptor subtypes (A1, A2A, A2B and
A3) have been cloned and characterized from several mammalian species
including humans and rats, and they all belong to the G-protein-coupled
receptor family (Fredholm et al., 2005). The effects of CAF on CNS appearto be mediated primarily by its antagonistic actions at the A1 and A2A
subtypes of adenosine receptors (Fredholm et al., 1999, 2001, 2005).
The ability of CAF to prevent memory impairment has been
reported (Mendonça and Cunha, 2010; Nehling et al., 2010; Ribeiro
and Sebastião, 2010). Costa et al. (2008) demonstrated that treatment
with CAF during 12 months prevents memory impairment in aging
mice. Positive actions of CAF on information processing and
performance might also be attributed to improvement of behavioral
routines, arousal enhancement and sensorimotor gating, and these
actions may be not solely related to A1 receptor function (Ribeiro and
Sebastião, 2010). However, some beneﬁcial effects triggered by CAF
were related to the preferential blockade of adenosine A2A receptors
(Fredholm et al., 2005). Moreover, it has been generally accepted that
caffeine and/or selective A2A receptor antagonists prevent memory
impairment associated with different insults affecting the brain such
as Alzheimer's disease (Arendash et al., 2006; Dall'Igna et al., 2007;
Cunha, 2008; Canas et al., 2009a, 2009b; Arendash et al., 2009),
diabetes (Duarte et al., 2009), convulsions (Cognato et al., 2010), sleep
deprivation (Alhaider et al., 2010) or attention-deﬁcit hyperactivity
disorder (Pires et al., 2009, 2010).
Not only CAF but also selective antagonists of receptors A2A, such
as SCH58261, can be used to ameliorate the memory impairment.
Prediger et al. (2005) have reported that A2A receptor antagonists
prevent memory impairment in animal models of aging. SCH58261
and CAF have the ability of preventing β-amyloid-induced cognitive
Scheme 1. Exposure design.
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2008; Canas et al., 2009a, 2009b).
Diverse behavioral tasks are used for evaluating alterations
occasioned in memory caused by the inﬂuence of aging, neurodegen-
erative diseases and other factors. The object recognition memory
test, developed by Ennaceur and Delacour (1988), is a non-spatial and
non-aversive memory test which has been increasingly used as a
important experimental tool in assessing drug effects on memory and
investigating the neural mechanisms underlying learning and
memory (Norman and Eacott, 2004). Thus, the present study was
designed to determine whether treatment with CAF and a selective
A2A receptor antagonist, SCH58261, reverses the memory impairment
and oxidative stress in aged rats.
2. Materials and methods
2.1. Animals
Male young (3 month-old, weighing 170–250 g) and aged
(23 month-old, weighing 550–700 g) rats were kept in groups during
aging and these animals were not exposed to any environmental
enrichment. Wistar rats were obtained from a local breeding colony.
Animals were kept in an air conditioned room (22±2 °C), on a 12 h
light/dark cycle. Commercial diet (Guaiba, RS, Brazil) and tap water
were supplied ad libitum. The animals were used according to the
guidelines of the Committee on Care and Use of Experimental Animal
Resources, the Federal University of Santa Maria, Brazil.
2.2. Drugs
2-(2-Furanyl)-7-(2-phenylethyl)-7H-pyrazolo[4,3-e][1,2,4]tria-
zolo[1,5-c]pyrimidin-5-amine (SCH58261, Sigma-Aldrich, Dorset, UK)
was dissolved in dimethyl sulfoxide (DMSO) (5 mg/ml) which was
further diluted in phosphate buffered saline (PBS) to give a ﬁnal
concentration of 15% DMSO (Fischer Scientiﬁc, Loughborough, UK) in
the drug injection solution. CAF was purchased from Sigma-Aldrich
(Dorset, UK) and dissolved in warmed PBS. All other chemicals were
of analytical grade and obtained from standard commercial suppliers.
2.3. Exposure
Seven to ten animals per group were usually tested in the
experiments. Both young and aged rats were treated orally (p.o.; by
gavage) with CAF (30 mg/kg body weight) or A2A receptor antagonist,
SCH58261 (0.5 mg/kg bodyweight), daily per 10 days (around10 a.m.).
The period of treatmentwas chosen because a period of circa 1–2 weeks
is required to offset the biochemical and behavioral consequences. The
doses were calculated as free base form. The dose of 30 mg/kg,
corresponding to the equivalent of 4–6 cups of coffee in humans, causes
the maximal behavior effects in rodents (Fredholm et al., 1999). The
dose of SCH58261 was chosen on the basis of previous study indicating
neuroprotection (Chen et al., 2001). The control groups of each age
received only vehicle (1 ml/kg p.o., daily per 10 days) (Scheme 1).
2.4. Behavioral tests
2.4.1. Novel object recognition memory
Twenty-four hours after the open ﬁeld test (OFT) (Scheme 1),
animals were trained and tested in a novel object recognition task as
previously described (De Lima et al., 2005). Training in the object
recognition task took place in the same arena used for the OFT, except
that the arena ﬂoor was covered with sawdust during the recognition
memory task training and test trials. The open ﬁeld exploration was
thus used as a context habituation trial for the recognition memory
task. The object recognition test required that the rats recalled which
of two plastic objects they had been previously familiarized with theenvironment where the test was performed. Twenty-four hours after
arena exploration, training was conducted by placing individual rats
into the ﬁeld, in which two identical objects (objects A1 and A2; duple
Lego toys) were positioned in two adjacent corners, 9 cm from the
walls. Animals were left to explore the objects until they had
accumulated 30 s of total object exploration time or for a maximum
of 20 min. In a short-term memory (STM) test given 1.5 h after
training, the rats explored the open ﬁeld for 5 min in the presence of
one familiar (A) and one novel (B) object. All objects presented similar
textures, colors and sizes, but distinctive shapes. A recognition index
calculated for each animal was expressed by the ratio TB/(TA+TB)
[TA=time spent exploring the familiar object A; TB=time spent
exploring the novel object B]. Between trials the objects were washed
with 10% ethanol solution. In a long-term memory (LTM) test given
24 h after training, the same rats explored the ﬁeld for 5 min in the
presence of familiar object A and a novel object C. Recognition
memory was evaluated as for the short-term memory test. Time
intervals for testing STM and LTM were chosen on the basis of
previous studies characterizing the neurochemical pathways mediat-
ing the formation of STM and LTM for object recognition (De Lima et
al., 2005) and other tasks (Quevedo et al., 2004) in rats. The
exploration of objects by the animal is traditionally deﬁned as
approaching the object headﬁrst within a short distance. In this
study, exploration was deﬁned as snifﬁng or touching the object with
the nose and/or forepaws. Sitting on the object was not considered
exploration. A longer exploration of the new object represents that
the animal remembers.
2.4.2. Open ﬁeld test (OFT)
In order to control for possible sensorimotor effects induced by
CAF and SCH58261, behavior during exploration of an open ﬁeld was
evaluated 24 h after the last injection (Scheme 1). The open ﬁeld was
a 40×45 cm arena surrounded by 50 cm high walls, made of plywood
with a frontal glass wall. The ﬂoor of the arena was divided into 9
(3×3) equal squares by black lines. Animals were placed in the rear
left corner and left to explore the ﬁeld freely for 5 min. Line crossings
and rearings were counted (Walsh and Cummins, 1976). Young and
aged animals used in the ﬁrst experiment (evaluation of possible age-
related impairment in object recognition memory) were also left to
explore the open ﬁeld for 5 min in order to allow animals to
familiarize with the arena used for object recognition training.
2.5. Biochemical determinations
After the behavioral test (Scheme 1), all rats were euthanized after
light isoﬂurane anesthesia. The brains of animals were removed,
dissected and kept on ice until the time of assay. The samples of whole
brains were homogenized in 50 mM Tris–HCl, pH 7.4 (1/5, w/v),
centrifuged at 4000×g for 10 min. The low-speed supernatants (S1)
were separated and used for biochemical assays.
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Fig. 1. Novel object recognition memory in young adult (3 months of age) and aged
(23 months of age) male rats. Data are median (interquartile ranges) recognition
indexes in short-term (STM) and long-term (LTM) retention test trials. N=7–10
animals per group. * pb0.05 compared to the LTM young group.
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Fig. 2. Novel object recognition memory in young and aged rats treated with a daily
administration of vehicle, caffeine (30 mg/kg, p.o.) or SCH58261 (0.5 mg/kg, p.o.) for
10 days. Animals were given a training trial in the object recognition memory task 48 h
after the last injection. Data are median (interquartile ranges) recognition indexes in
short-term (STM) (A) and long-term (LTM) (B) retention test trials. N=7–10 animals
per group. * pb0.05 compared to the respective control group.
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Ascorbic acid (vitamin C), a non-enzymatic antioxidant defense
that is involved in protecting against the injurious effects of RS, was
measured in the brain of young and aged rats. Ascorbic acid level
determination was performed as described by Jacques-Silva et al.
(2001) with some modiﬁcations. Brieﬂy, S1 was precipitated in 10%
trichloroacetic acid solution. An aliquot of the supernatant (300 μl) at
a ﬁnal volume of 575 μl of the solution was incubated at 38 °C for 3 h
then 500 μl H2SO4 65% (v/v) was added to the medium. The reaction
product was determined using a color reagent containing 4.5 mg/ml
dinitrophenyl hydrazine and CuSO4 (0.075 mg/ml) at 520 nm. The
content of ascorbic acid is related to tissue amount (μmol ascorbic
acid/g tissue).
2.5.2. Oxygen and nitrogen reactive species levels
In order to determine the presence of oxidative imbalance caused
by age factor, oxygen and nitrogen reactive species levels in brain
from young and aged rats weremeasured. S1 was incubated with 10 μl
of 1 mM 2′,7′ dichloroﬂuorescein diacetate (DCHF-DA). The oxygen
and nitrogen reactive species levels were determined by a spectro-
ﬂuorimetric method, using DCHF-DA assay. The oxidation of DCHF-DA
to ﬂuorescent dichloroﬂuorescein is measured for the detection of
intracellular oxygen and nitrogen reactive species. The DCF ﬂuores-
cence intensity emission was recorded at 520 nm (with 480 nm
excitation) 15 min after the addition of DCHF-DA to the medium. The
results were expressed as arbitrary units (AU).
2.5.3. Na+K+ ATPase activity
Na+K+ ATPase, a well-known SH-containing enzyme found in the
brain, is highly sensitive to pro-oxidant elements (Carfagna et al.,
1996). The reaction mixture for Na+K+ ATPase activity assay
contained 50 μl of S1, 3 mM MgCl2, 125 mM NaCl, 20 mM KCl and
50 mM Tris/HCl, pH 7.4, in a ﬁnal volume of 500 μl. The reaction was
initiated by the addition of ATP to a ﬁnal concentration of 3.0 mM.
Control samples were carried out under the same conditions with the
addition of 0.1 mM ouabain. The samples were incubated at 37 °C for
30 min, the incubation was stopped by adding trichloroacetic acid
solution (10% TCA). Na+K+ ATPase activity was calculated by the
difference found between two assays (with and without ouabain).
Released inorganic phosphate (Pi) was measured by the method of
Fiske and Subbarow (1925) (nmol Pi/mg protein/min).
2.6. Protein quantiﬁcation
Protein concentration was measured by the method of Bradford
(1976), using bovine serum albumin as the standard.
2.7. Statistical analysis
Data are expressed as means±S.E.M. The statistical signiﬁcance
was assessed by analysis of variance (ANOVA). One-way ANOVA was
used to assess the age effect (Fig. 1). Two-way ANOVA was used to
assess the effect of age (young and aged) and treatment (CAF and
SCH58261) (Figs. 2–6). Post hoc Duncan's test was carried out when
appropriated. A value of pb0.05 was considered to be signiﬁcant.
3. Results
3.1. Novel object recognition memory
In the STM retention test, there was no signiﬁcant difference
between groups (One-way ANOVA of young×aged, pN0.05). In the
LTM retention test, one-way ANOVA revealed a signiﬁcant decrease in
recognition index of aged rats (pb0.05) (Fig. 1).
A signiﬁcant main effect of CAF [F(1,32)=11.35, pb0.001] was
found on object recognition memory in STM retention in young andaged rats (Two-way ANOVA). Post hoc comparisons showed an
increase in STM retention in young and aged rats treated with CAF
when compared to the respective controls (Fig. 2A).
Two-way ANOVA of STM retention data showed a signiﬁcant main
effect of SCH58261 treatment [F(1,32)=12.08, pb0.001]. Post hoc
comparisons revealed an increase in STM retention in young and aged
rats treatedwith SCH58261when compared to the respective controls
(Fig. 2A).
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Fig. 3.Open ﬁeld behavior in young and aged rats treated with a daily systemic injection
of vehicle, caffeine (30 mg/kg) or SCH58261 (0.5 mg/kg) for 10 days. Animals were left
to explore the arena for 5 min 24 h after the last injection. Data are mean+SEM
number of crossings (A) and number of rearings (B). N=7–10 animals per group.
*Pb0.05 compared to the young control group.
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Fig. 5. Effect of CAF and SCH58261 on RS levels in young adult and aged male rats.
Results are expressed as mean±S.E.M. of seven to ten animals per group. *pb0.05
compared to the young control group (two-way ANOVA/Duncan). #pb0.05 compared
to the control group of each age (two-way ANOVA/Duncan).
312 M.R. Leite et al. / Experimental Gerontology 46 (2011) 309–315Two-way ANOVA of LTM retention data revealed a CAF×age
interaction [F(1,32)=1.86, pb0.04] (Fig. 2B). Treatment with CAF
[F(1,32)=5.44, pb0.01] signiﬁcantly increase LTM retention in aged
and young rats when compared to the respective controls. Two-way
ANOVA of LTM retention data revealed a SCH58261×age interaction
[F(1,32)=6.12, p=0.01]. Post hoc comparisons showed a signiﬁcant
increase in LTM retention in aged and young rats treated with
SCH58261 [F(1,32)=19.99, pb0.001] (Fig. 2B).0
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Fig. 4. Effect of CAF and SCH58261 on ascorbic acid levels in young adult and aged male
rats. Results are expressed as mean±S.E.M. of seven to ten animals per group. *pb0.05
compared to the young control group (two-way ANOVA/Duncan).3.2. Open ﬁeld test
Two-way ANOVA (CAF×age) performed on the number of cross-
ings showed a signiﬁcant main effect of age [F(1,32)=24.14,
pb0.001]. Post hoc comparisons demonstrated that the decrease in
the number of squares crossed by aged rats was not protected by CAF
[F(1,32)=0.42, pb0.52] (Fig. 3).
Two-way ANOVA (SCH58261×age) of the number of crossings
demonstrated a signiﬁcant main effect of age [F(1,32)=32.04,
pb0.001]. Post hoc comparisons revealed that SCH58261 was not
effective in protecting against the decrease in the number of squares
crossed caused by age [F(1,32)=0.57, pb0.45)].
Neither age nor treatment affected the number of rearings
(pN0.05) (Fig. 3B).3.3. Ascorbic acid levels
A signiﬁcant main effect of age [F(1,32)=35.65, pb0.001] on
ascorbic acid levels was found (Two-way ANOVA). Treatment with
CAF [F(1,32)=0.08, p=0.88] or SCH58261 [F(1,32)=0.12, p=0.91]
did not change the decrease in basal ascorbic acid levels in brain of
aged rats. Ascorbic acid levels were not altered in all groups of young
rats (Fig. 4).0
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Fig. 6. Effect of CAF and SCH58261 on Na+ K+ ATPase activity in young adult and aged
male rats. Results are expressed as mean±S.E.M. of seven to ten animals per group.
*pb0.05 compared to the young control group (two-way ANOVA/Duncan). #pb0.05
compared to the control group of each age (two-way ANOVA/Duncan).
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Two-way ANOVA (age×CAF) on oxygen and nitrogen reactive
species levels revealed a signiﬁcant main effect of age [F(1,32)=
13.56, pb0.001]. Treatment with CAF [F(1,32)=12.01, pb0.001]
signiﬁcantly reduced oxygen and nitrogen reactive species levels
increased in brains of aged rats (Fig. 5).
Two-way ANOVA (age×SCH58261) on oxygen and nitrogen react-
ive species levels demonstrated a signiﬁcant interaction [F(1,32)=
5.66, pb0.02]. Treatment with SCH58261 [F(1,32)=11.23, pb0.001]
reduced oxygen and nitrogen reactive species levels increased in
brains of aged rats [F(1,32)=17.66, pb0.001] (Fig. 5). The levels of
oxygen and nitrogen reactive species were not altered in young rats
from all groups.
3.5. Na+K+ ATPase activity
Two-way ANOVA (age×CAF) of Na+K+ ATPase activity revealed a
treatment×age interaction [F(1,32)=4.55, pb0.01]. Treatment with CAF
[F(1,32)=15.02, pb0.001] signiﬁcantly increased Na+K+ATPase activity
inhibited in brains of aged rats [F(1,32)=21.34, pb0.001] (Fig. 6).
Two-way ANOVA (age×SCH58261) of Na+K+ ATPase activity
showed a signiﬁcant interaction [F(1,32)=6.10, pb0.01]. SCH58261
[F(1,32)=13.89, pb0.001] was effective in increasing Na+K+ ATPase
activity inhibited in brains of aged rats [F(1,32)=17.89, pb0.001].
Na+K+ ATPase activity was not altered in all groups of young rats
(Fig. 6).
4. Discussion
In this study we provide evidence for an age-related deﬁcit in
novel object recognition memory in rats. CAF or SCH58261,
antagonists of adenosine receptors, reverses memory impairment in
aged rats. This study also demonstrated the inﬂuence of age on
locomotor activity. Moreover, CAF or SCH58261 ameliorated the index
of recognition in young animals.
The antioxidant action of CAF and SCH58261 could be related to the
reverse inmemory impairment since they restoredoxygenandnitrogen
reactive species levels and Na+K+ ATPase activity altered in aged rats.
Like humans, aged rodents exhibit age-related decline in cognitive
function (Erickson and Barnes, 2003). The novel object recognition
memory task evaluates natural behavior of rodents, such as
approaching and exploring novel objects rather than familiar ones.
Thus this task deals with the natural motivation of the animals to
explore novelty, an innate instinct that animals use to recognize their
environment (Heldt et al., 2007). The novel object recognition
memory test has been widely used in the investigation of the
neurobiological mechanisms of learning and memory. Whereas most
studies investigating learning and memory in rodents use spatial and/
or emotionally motivated behavioral tasks, the object recognition task
provides a tool for assessing non-spatial, non-aversive memory
sensitive to genetic and pharmacological manipulations as well as
aging process (De Lima et al., 2005; Schröder et al., 2003).
The present study investigated the hypothesis that treatment with
CAF or SCH58261 attenuates age-related memory deﬁcits using the
novel object recognition memory task. It was clearly demonstrated an
age related deﬁcit in novel object recognition memory in the LTM
retention test. Accordingly, De Lima et al. (2005) have reported an age
related deﬁcit in novel object recognition memory measured 24 h
after training in rats and the absence of effect in the STM retention
test. The memory deﬁcit was reversed by treatment with CAF or
SCH58261 in aged animals. In addition, CAF or SCH58261 improved
the novel object recognition memory in young rats. Taken into
consideration these results, it is tempting to speculate the beneﬁcial
role of A2A and A1 receptor antagonists as CAF or A2A receptor
antagonist selective, SCH58261, on cognitive deﬁcit caused by aging.There is also considerable evidence that CAF presents cognition
enhancing properties (Gevaerd et al., 2001; Costenla et al., 2010;
Mendonça and Cunha, 2010; Ribeiro and Sebastião, 2010) and its use
has been proposed as a potential treatment to counteract age-related
cognitive decline (Riedel and Jolles, 1996; Cunha and Agostinho,
2010). A modulatory role of adenosine in learning and memory,
including processes such as long-term potentiation (LTP) (de
Mendonça and Ribeiro, 1994) and long-term depression (LTD)
(Mendonça et al., 1997) that are considered to be basic mechanisms
involved in memory processes, has been proposed. Prediger et al.
(2005) have reported that adenosine modulates the short-term social
memory in rats by acting on both A1 and A2A receptors, with
adenosine receptor agonists and antagonists, respectively, disrupting
and enhancing the social memory.
It is important to point out that there is amain difference in this study
compared with others investigating the effects of CAF and A2A receptor
antagonists onmemoryperformance (Angelucci et al., 1999;Corodimaset
al., 2000; Costa et al., 2008; Takahashi et al., 2008). In the present study,
CAF and SCH58261, an A2A receptor antagonist, ameliorated memory
performance both in control subjects (adult rats) and in test (aged) rats.
Even though, there seems to be a general consensus in the literature that
chronic CAF consumption is not amemory enhancer but rather amemory
stabilizer (Cunha and Agostinho, 2010). An explanation for this difference
is that the effects of CAF depend on the tested dose, the schedule of
administration (acute versus chronic), the timing of administration
(before training, affecting memory acquisition, or after training, affecting
memory consolidation or retrieval) and on the mode of administration
(locally in deﬁnedbrain structures or peripherally affectingdifferent brain
structures) (Takahashi et al., 2008; Cunha, 2008).
Clearly, the different impact of CAF and A2A receptor antagonists
on memory performance is related to changes in adenosine receptor
expression, density on aging (Cunha et al., 1995; Alfaro et al., 2004;
Canas et al., 2009a, 2009b) and functional properties of adenosine A2A
receptors (Lopes et al., 1999; Corsi et al., 1999, 2000; Rebola et al.,
2003; Rodrigues et al., 2008).
Treatment with CAF or SCH58261 was not able to reverse a
decrease in the number of crossings in aged animals. Accordingly,
Pardon et al. (2000) tested the behavioral parameters of different age
of rats (5, 11, 17 and 23 months) in the OFT and argued that locomotor
activity and exploring behavior decrease with the age. However, there
was no effect of age in the number of rearings, in the present study.
Additionally, the current study showed that CAF or SCH58261
treatment partially decreased RS levels increased in aged animals.
Although the major factors involved in age-related decline remain to
be speciﬁed, oxidative stress generated by RS has been mainly
implicated in cognitive impairment and neuropathological disorders
in both old experimental animals and aged humans (Liu et al., 2003).
It is possible that due to its antioxidant action, CAF reduced the levels
of oxygen and nitrogen reactive species in the brain of aged rats,
resulting in the improvement of the performance of aged animals in
the novel object recognition memory task.
In addition, both adenosine receptors, A1/A2A, have the ability to
control neuronal damage after different insults: A1 receptors
constitute a hurl that increases the threshold for brain damage,
whereas the blockade of adenosine A2A receptors affords neuropro-
tection against chronic noxious brain insults (Cunha, 2005). A2A
receptors affect the impact and formation of free radicals in neuronal
preparations (Masino et al., 1999; Rego et al., 1999; Agostinho et al.,
2000; Behan and Stone, 2002; Almeida et al., 2003). In addition, there
has been demonstrated the impact of A2A receptors on NMDA
receptors (Hussey et al., 2007; Rebola et al., 2008) and on
mitochondrial function (Silva et al., 2007), i.e., the main triggers of
oxidative stress in brain tissue. Thus, the antagonistic effects of both
CAF and SCH58261 could also be involved in reducing oxygen and
nitrogen reactive species levels in aged rats, but more studies are
needed to support this assertion.
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are determined as parameters of oxidative stress (Jayakumar et al.,
2007). The results presented in this study clearly showed that aging
depressed ascorbic acid levels in the brains of old rats. Antioxidant
function in the brain declines during aging (Siqueira et al., 2005).
Shahidi et al. (2008) concluded that short- and long-term supple-
mentationwith ascorbic acid has facilitatory effects on acquisition and
retrieval processes of passive avoidance learning and memory in rats.
Moreover, an observational study in elderly individuals indicated that
ascorbic acid may have beneﬁcial effect on the development of
Alzheimer dementia (Landmark, 2006). Plasma ascorbic acid levels
were lower in subjects with dementia compared to controls (Charlton
et al., 2004), and it was suggested that ascorbic acid might protect
against cognitive impairment (Paleologos et al., 1998). In this context,
we suggest that the depressed ascorbic acid levels are associated with
the cognitive impairment in aged rats.
The results on Na+ K+ ATPase activity are in accordance with Kaur
et al. (2001) who demonstrated the age-related decline in Na+ K+
ATPase activity. Thus, it is possible that oxidative stress (decrease in
ascorbic acid and increase of oxygen and nitrogen reactive species
levels) and inhibition of Na+ K+ ATPase activity have some inﬂuence
in the cognitive deﬁcit in aged rats. As previously reported, the
decreased activity of Na+K+ATPase is the consequence of either aging
or peroxidative process. Such effect might depend on themodiﬁcation
of the lipidic composition and decreased membrane ﬂuidity, which
occurs during aging (Viani et al., 1991). In this study, treatment with
CAF or SCH58261was effective in normalizing Na+ K+ ATPase activity
inhibited in aged rats. In this context, Bavaresco et al. (2003) have
reported that vitamins E and C prevent the inhibition of Na+K+
ATPase activity. The inhibition of Na+K+ ATPase activity has been
related to memory consolidation of step-down inhibitory avoidance
in the hippocampus (Wyse et al., 2004). Thus, the increase in Na+K+
ATPase activity by CAF or SCH58261 may be involved in the
improvement of memory in aged rats.
In the CNS, the increase of the neuronal excitability would
consume more cell energy. It has been shown that approximately
one half or more of total ATP generated in brain at resting state is
consumed by Na+K+ATPase to maintain proper transmembrane ionic
gradients (Erecinska and Silver, 1989). Establishing and maintaining
high K+ and low Na+ in the cytoplasm are required for normal resting
membrane potentials and various cellular activities. Taken these into
consideration, the decrease in Na+K+ATPase activity consequently,
reducing the Na+ and K+ electrochemical gradient, and disturbed the
ionic homeostasis and the physiological functions of neurons, could be
related to the impairment of spatial recognition memory in aged rats.
It has been well documented the importance of Na+K+ATPase
activity in the spatial recognition memory (Hu et al., 2010), in
learning (Brunelli et al., 1997) and in activity-dependent synaptic
plasticity, such as long-term potentiation (LTP) (Glushchenko and
Izvarina, 1997). In this context, Na+K+ATPase inhibition by ouabain
impairs learning and memory in Morris water maze (Zhan et al.,
2004) and step-through passive avoidance tasks (Gibbs and Ng, 1977;
Ng and Gibbs, 1991; Sato et al., 2004), further supporting the main
role of this enzyme on learning and memory.
In summary, the present study demonstrated that CAF and
SCH58261, modulators of adenosinergic receptors, were able to reverse
age-associated memory impairment and to partially reduce oxidative
stress, suggesting its use in the treatment of cognitive decline associated
with aging. However, more studies are needed to unravel the exact
mechanisms by which CAF and SCH58261 improve memory.
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